Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Negative-control-anchored urinary microbiome profiling with absolute 16S quantification : a pilot study in newly diagnosed, treatment-naive bladder cancer and healthy individuals
ID
Accetto, Tomaž
(
Author
),
ID
Strašek Smrdel, Katja
(
Author
),
ID
Taskovska, Milena
(
Author
),
ID
Starčič Erjavec, Marjanca
(
Author
),
ID
Smrkolj, Tomaž
(
Author
),
ID
Seme, Katja
(
Author
),
ID
Erdani-Kreft, Mateja
(
Author
)
PDF - Presentation file,
Download
(971,06 KB)
MD5: 9C063499DA5FA27245611676CD1CE3A1
URL - Source URL, Visit
https://academic.oup.com/femsle/article/doi/10.1093/femsle/fnag020/8488588
Image galllery
Abstract
Recent studies utilizing 16S rRNA amplicon sequencing have challenged the notion of urine sterility, yet urine is a low-biomass specimen in which apparent community profiles can be strongly influenced by background signal from reagents and processing. To address this interpretability gap, we integrate culture-independent absolute 16S rRNA gene quantification with urinary 16S amplicon sequencing in a negative-control-anchored workflow. Bacterial load provides a biomass-aware quality control gate that defines interpretable low-biomass thresholds and objective exclusion criteria. As a pilot application, we compared midstream urine collected prior to instrumentation from healthy volunteers and newly diagnosed bladder cancer (BC) patients, quality filtering retained 29 controls and 5 BC cases. Samples > 106 copies/ml typically produced > 10 000 reads; near 105 copies/mlread counts dropped sharply yetremained distinguishable from background. Thirteen negative controls (V3–V4 PCR and stabilization buffer; median 90, mean 124 reads) supported excluding samples with < 1000 reads. Median bacterial load was lower in BC than in controls (7.0 × 103 vs 1.07 × 106 copies/ml), although not significant in this underpowered cohort (P = 0.07). This cohort-size-independent framework enables load-based triage for sequencing, reduces backgrounddriven over-interpretation in low-biomass urine datasets, and supports modeling bacterial load as a covariate or stratifier in future studies of the bladder cancer microbiome.
Language:
English
Keywords:
bladder cancer
,
midstream urine
,
microbiota
,
urinary tract infection
,
next-generation sequencing
,
nonmetric multidimensional scaling
,
absolute quantification
,
negative controls
,
low biomass
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2026
Number of pages:
8 str.
Numbering:
Vol. 373, art. fnag020
PID:
20.500.12556/RUL-185282
UDC:
579:616.6
ISSN on article:
0378-1097
DOI:
10.1093/femsle/fnag020
COBISS.SI-ID:
272226819
Publication date in RUL:
30.07.2026
Views:
164
Downloads:
70
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
FEMS microbiology letters
Shortened title:
FEMS microbiol. lett.
Publisher:
Oxford University Press
ISSN:
0378-1097
COBISS.SI-ID:
25455104
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
rak mehurja
,
srednji tok urina
,
mikrobiota
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J7-2594
Name:
Uporaba amnijske membrane za inovativno multimodalno zdravljenje bakterijskega cistitisa in raka sečnega mehurja: učinek njene protimikrobne, imunomodulatorne in protirakave aktivnosti
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0108
Name:
Celična biologija in molekularna genetika v biomedicini
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
IP-0510
Name:
Mreža raziskovalnih infrastrukturnih centrov
Acronym:
MRIC UL
Funder:
MIZS - Ministrstvo za izobraževanje, znanost in šport Republike Slovenije
Name:
ELIXIR
Acronym:
RI-SI-ELIXIR 2
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back